Peter Niehoff

3.7k total citations
53 papers, 1.7k citations indexed

About

Peter Niehoff is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Surgery. According to data from OpenAlex, Peter Niehoff has authored 53 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pulmonary and Respiratory Medicine, 18 papers in Cancer Research and 16 papers in Surgery. Recurrent topics in Peter Niehoff's work include Breast Cancer Treatment Studies (18 papers), Advanced Radiotherapy Techniques (14 papers) and Prostate Cancer Diagnosis and Treatment (12 papers). Peter Niehoff is often cited by papers focused on Breast Cancer Treatment Studies (18 papers), Advanced Radiotherapy Techniques (14 papers) and Prostate Cancer Diagnosis and Treatment (12 papers). Peter Niehoff collaborates with scholars based in Germany, Switzerland and Austria. Peter Niehoff's co-authors include György Kovács, Csaba Polgár, Tibor Major, Vratislav Strnad, José Luis Guinot, Erik Van Limbergen, Yahya Açil, B. Kimmig, Jörg Wiltfang and Bengt Johansson and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Peter Niehoff

51 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Niehoff Germany 20 766 632 521 396 388 53 1.7k
Marie‐Luise Sautter‐Bihl Germany 20 436 0.6× 160 0.3× 291 0.6× 332 0.8× 486 1.3× 44 1.2k
Murat Beyzadeoğlu Türkiye 34 147 0.2× 369 0.6× 967 1.9× 525 1.3× 735 1.9× 139 2.9k
Zoltán Takácsi‐Nagy Hungary 19 918 1.2× 577 0.9× 219 0.4× 332 0.8× 518 1.3× 75 1.4k
Takeshi Kodaira Japan 29 155 0.2× 387 0.6× 1.2k 2.3× 807 2.0× 1.1k 2.8× 218 2.6k
Felix Sedlmayer Austria 33 1.5k 1.9× 1.3k 2.0× 1.0k 1.9× 730 1.8× 649 1.7× 149 2.9k
Jonathan E. Leeman United States 24 131 0.2× 266 0.4× 720 1.4× 319 0.8× 319 0.8× 104 1.5k
Michael Lotter Germany 22 501 0.7× 534 0.8× 283 0.5× 281 0.7× 397 1.0× 67 1.2k
W.M. Sze China 19 276 0.4× 287 0.5× 992 1.9× 1.5k 3.9× 2.3k 5.8× 31 3.4k
Jerry L. Barker United States 17 239 0.3× 816 1.3× 780 1.5× 421 1.1× 402 1.0× 36 1.8k
S.B. Oei Netherlands 9 945 1.2× 316 0.5× 262 0.5× 612 1.5× 341 0.9× 15 1.4k

Countries citing papers authored by Peter Niehoff

Since Specialization
Citations

This map shows the geographic impact of Peter Niehoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Niehoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Niehoff more than expected).

Fields of papers citing papers by Peter Niehoff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Niehoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Niehoff. The network helps show where Peter Niehoff may publish in the future.

Co-authorship network of co-authors of Peter Niehoff

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Niehoff. A scholar is included among the top collaborators of Peter Niehoff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Niehoff. Peter Niehoff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Koerber, Stefan A., Stefan Höcht, Daniel M. Aebersold, et al.. (2024). Prostate cancer and elective nodal radiation therapy for cN0 and pN0—a never ending story?. Strahlentherapie und Onkologie. 200(3). 181–187. 1 indexed citations
3.
Pinkawa, Michael, Daniel M. Aebersold, Dirk Böhmer, et al.. (2021). Radiotherapy in nodal oligorecurrent prostate cancer. Strahlentherapie und Onkologie. 197(7). 575–580. 9 indexed citations
4.
Shelan, Mohamed, Daniel M. Aebersold, Dirk Böhmer, et al.. (2021). Moderately hypofractionated radiotherapy as definitive treatment for localized prostate cancer: Pattern of practice in German-speaking countries. Strahlentherapie und Onkologie. 197(11). 993–1000. 4 indexed citations
5.
Sedlmayer, Felix, Daniel M. Aebersold, Dirk Böhmer, et al.. (2020). Ultrahypofractionation of localized prostate cancer. Strahlentherapie und Onkologie. 197(2). 89–96. 20 indexed citations
6.
Niehoff, Peter. (2019). SP-0345 Single catheter balloon brachytherapy (Mammosite, Contura). Radiotherapy and Oncology. 133. S174–S174.
7.
Beck, Marcus, Dirk Böhmer, Daniel M. Aebersold, et al.. (2019). Role of combined radiation and androgen deprivation therapy in intermediate-risk prostate cancer. Strahlentherapie und Onkologie. 196(2). 109–116. 8 indexed citations
8.
Salembier, Carl, et al.. (2013). Prospective multi-center dosimetry study of low-dose Iodine-125 prostate brachytherapy performed after transurethral resection. Journal of Contemporary Brachytherapy. 2(2). 63–69. 14 indexed citations
9.
Hannoun‐Lévi, Jean‐Michel, Alexandra Resch, Jocelyn Gal, et al.. (2013). Accelerated partial breast irradiation with interstitial brachytherapy as second conservative treatment for ipsilateral breast tumour recurrence: Multicentric study of the GEC-ESTRO Breast Cancer Working Group. Radiotherapy and Oncology. 108(2). 226–231. 104 indexed citations
10.
Hoskin, Peter, Alessandro Colombo, Ann Henry, et al.. (2013). GEC/ESTRO recommendations on high dose rate afterloading brachytherapy for localised prostate cancer: An update. Radiotherapy and Oncology. 107(3). 325–332. 201 indexed citations
11.
Açil, Yahya, Matthias Gierloff, Björn Möller, et al.. (2012). Effects of Zoledronate on Irradiated Bone In Vivo: Analysis of the Collagen Types I, V and Their Cross-links Lysylpyridinoline, Hydroxylysylpyridinoline and Hydroxyproline. Calcified Tissue International. 92(3). 251–260. 11 indexed citations
12.
Polgár, Csaba, Erik Van Limbergen, Richard Pötter, et al.. (2010). Patient Selection for Accelerated Partial Breast Irradiation after Breast-conserving Surgery: Recommendations of the Groupe Européen de Curiethérapie-European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) Breast Cancer Working Group. International Journal of Radiation Oncology*Biology*Physics. 78(3). S243–S243. 3 indexed citations
14.
Simon, Maciej J. K., Peter Niehoff, B. Kimmig, Jörg Wiltfang, & Yahya Açil. (2009). Expression profile and synthesis of different collagen types I, II, III, and V of human gingival fibroblasts, osteoblasts, and SaOS-2 cells after bisphosphonate treatment. Clinical Oral Investigations. 14(1). 51–58. 47 indexed citations
15.
Niehoff, Peter, Ingo N. Springer, Yahya Açil, et al.. (2008). HDR brachytherapy irradiation of the jaw – as a new experimental model of radiogenic bone damage. Journal of Cranio-Maxillofacial Surgery. 36(4). 203–209. 41 indexed citations
16.
Springer, Ingo N., Peter Niehoff, Yahya Açil, et al.. (2007). BMP-2 and bFGF in an irradiated bone model. Journal of Cranio-Maxillofacial Surgery. 36(4). 210–217. 55 indexed citations
18.
Springer, Ingo N., Peter Niehoff, Patrick H. Warnke, et al.. (2005). Radiation caries—radiogenic destruction of dental collagen. Oral Oncology. 41(7). 723–728. 65 indexed citations
19.
Wilhelm, R., et al.. (1998). Prophylaxe und Therapie akuter Strahlenfolgen an Haut und Schleimhaut. Teil I: Ergebnisse einer bundesweiten Erhebung. Strahlentherapie und Onkologie. 174(3). 142–148. 10 indexed citations
20.
Niehoff, Peter, et al.. (1998). Prophylaxe und Therapie akuter Strahlenfolgen an Haut und Schleimhaut. Strahlentherapie und Onkologie. 174(4). 193–199. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026